Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity

Gastroenterology

Volumn 151, Issue 4, 2016, Pages 670-683

  Caminero, Alberto ^a   Galipeau, Heather J ^a   McCarville, Justin L ^a   Johnston, Chad W ^b   Bernier, Steve P ^a   Russell, Amy K ^c,d   Jury, Jennifer ^a   Herran, Alexandra R ^e   Casqueiro, Javier ^e   Tye Din, Jason A ^c,d,f   Surette, Michael G ^a,b   Magarvey, Nathan A ^b   Schuppan, Detlef ^g   Verdu, Elena F ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF LEÓN   (Spain)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

^g JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Celiac Disease; Gluten Metabolism; Intestinal Inflammation; Intestinal Microbiota

Indexed keywords

ELASTASE; GLUTEN; HLA DQ2 ANTIGEN; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BACTERIAL COLONIZATION; CELIAC DISEASE; COMMENSALISM; CONTROLLED STUDY; DEAMINATION; DUODENUM; ENZYME ACTIVITY; HOST SUSCEPTIBILITY; HUMAN; IMMUNOGENICITY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION RISK; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS WARNERI; SUSCEPTIBLE POPULATION; T LYMPHOCYTE ACTIVATION; ANIMAL; BACTERIAL TRANSLOCATION; C57BL MOUSE; CASE CONTROL STUDY; GENETICS; IMMUNOGENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; BACTERIAL TRANSLOCATION; CASE-CONTROL STUDIES; CELIAC DISEASE; DUODENUM; GLUTENS; HUMANS; IMMUNOGENETIC PHENOMENA; LACTOBACILLUS; MICE; MICE, INBRED C57BL; PSEUDOMONAS AERUGINOSA; T-LYMPHOCYTES;

EID: 84989908021     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.06.041     Document Type: Article

References (51)

1. 1 Leonard, M.M., Vasagar, B., US perspective on gluten-related diseases. Clin Exp Gastroenterol 7 (2014), 25–37.
2. 2 Ludvigsson, J.F., Leffler, D.A., Bai, J.C., et al. The Oslo definitions for coeliac disease and related terms. Gut 62 (2013), 43–52.
3. 3 Shan, L., Molberg, O., Parrot, I., et al. Structural basis for gluten intolerance in celiac sprue. Science 297 (2002), 2275–2279.
4. 4 Hardy, M.Y., Girardin, A., Pizzey, C., et al. Consistency in polyclonal T-cell responses to gluten between children and adults with celiac disease. Gastroenterology 149 (2015), 1541–1552 e2.
5. 5 Dieterich, W., Ehnis, T., Bauer, M., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3 (1997), 797–801.
6. 6 Kim, C.Y., Quarsten, H., Bergseng, E., et al. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A 101 (2004), 4175–4179.
7. 7 Verdu, E.F., Galipeau, H.J., Jabri, B., Novel players in coeliac disease pathogenesis: role of the gut microbiota. Nat Rev Gastroenterol Hepatol 12 (2015), 497–506.
8. 8 Nadal, I., Donat, E., Ribes-Koninckx, C., et al. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol 56 (2007), 1669–1674.
9. 9 Wacklin, P., Laurikka, P., Lindfors, K., et al. Altered duodenal microbiota composition in celiac disease patients suffering from persistent symptoms on a long-term gluten-free diet. Am J Gastroenterol 109 (2014), 1933–1941.
10. 10 D'Argenio, V., Casaburi, G., Precone, V., et al. Metagenomics reveals dysbiosis and a potentially pathogenic N flavescens strain in duodenum of adult celiac patients. Am J Gastroenterol 111 (2016), 879–890.
11. 11 Caminero, A., Herran, A.R., Nistal, E., et al. Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease. FEMS Microbiol Ecol 88 (2014), 309–319.
12. 12 Fernandez-Feo, M., Wei, G., Blumenkranz, G., et al. The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity. Clin Microbiol Infect 19 (2013), E386–E394.
13. 13 Bethune, M.T., Khosla, C., Oral enzyme therapy for celiac sprue. Methods Enzymol 502 (2012), 241–271.
14. 14 Slack, E., Hapfelmeier, S., Stecher, B., et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 325 (2009), 617–620.
15. 15 Galipeau, H.J., McCarville, J.L., Huebener, S., et al. Intestinal microbiota modulates gluten-induced immunopathology in humanized mice. Am J Pathol 185 (2015), 2969–2982.
16. 16 Dewhirst, F.E., Chien, C.C., Paster, B.J., et al. Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl Environ Microbiol 65 (1999), 3287–3292.
17. 17 Herran, A.R., Role of human Microbiota in Gluten Metabolism. Molecular Biology and Biotechnology. 2015, Universidad de Leon, Leon, Spain.
18. 18 Nistal, E., Caminero, A., Herran, A.R., et al. Study of duodenal bacterial communities by 16s rRNA gene analysis in adults with active celiac disease versus non celiac disease controls. J Appl Microbiol 120 (2016), 1691–1700.
19. 19 Sanchez, E., Ribes-Koninckx, C., Calabuig, M., et al. Intestinal Staphylococcus spp. and virulent features associated with coeliac disease. J Clin Pathol 65 (2012), 830–834.
20. 20 de Meij, T.G., Budding, A.E., Grasman, M.E., et al. Composition and diversity of the duodenal mucosa-associated microbiome in children with untreated coeliac disease. Scand J Gastroenterol 48 (2013), 530–536.
21. 21 Caminero, A., Nistal, E., Herran, A.R., et al. Differences in gluten metabolism among healthy volunteers, coeliac disease patients and first-degree relatives. Br J Nutr 114 (2015), 1157–1167.
22. 22 Nistal, E., Caminero, A., Vivas, S., et al. Differences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patients. Biochimie 94 (2012), 1724–1729.
23. 23 Whelan, F.J., Verschoor, C.P., Stearns, J.C., et al. The loss of topography in the microbial communities of the upper respiratory tract in the elderly. Ann Am Thorac Soc 11 (2014), 513–521.
24. 24 Masella, A.P., Bartram, A.K., Truszkowski, J.M., et al. PANDAseq: paired-end assembler for illumina sequences. BMC Bioinform, 13, 2012, 31.
25. 25 Ye, Y., Identification and quantification of abundant species from pyrosequences of 16S rRNA by Consensus Alignment. Proceedings (IEEE Int Conf Bioinformatics Biomed) 2010 (2011), 153–157.
26. 26 Moron, B., Bethune, M.T., Comino, I., et al. Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide. PLoS One, 3, 2008, e2294.
27. 27 Helmerhorst, E.J., Zamakhchari, M., Schuppan, D., et al. Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity. PLoS One, 5, 2010, e13264.
28. 28 Caminero, A., Nistal, E., Arias, L., et al. A gluten metabolism study in healthy individuals shows the presence of faecal glutenasic activity. Eur J Nutr 51 (2012), 293–299.
29. 29 Ibrahim, A., Yang, L., Johnston, C., et al. Dereplicating nonribosomal peptides using an informatic search algorithm for natural products (iSNAP) discovery. Proc Natl Acad Sci U S A 109 (2012), 19196–19201.
30. 30 Tye-Din, J.A., Stewart, J.A., Dromey, J.A., et al. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci Transl Med, 2, 2010, 41ra51.
31. 31 Natividad, J.M., Huang, X., Slack, E., et al. Host responses to intestinal microbial antigens in gluten-sensitive mice. PLoS One, 4, 2009, e6472.
32. 32 Tian, N., Wei, G., Schuppan, D., et al. Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease. Am J Physiol Gastrointest Liver Physiol 307 (2014), G769–G776.
33. 33 Liberati, N.T., Urbach, J.M., Miyata, S., et al. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci U S A 103 (2006), 2833–2838.
34. 34 Anderson, R.P., Degano, P., Godkin, A.J., et al. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 6 (2000), 337–342.
35. 35 Menard, S., Lebreton, C., Schumann, M., et al. Paracellular versus transcellular intestinal permeability to gliadin peptides in active celiac disease. Am J Pathol 180 (2012), 608–615.
36. 36 Rahme, L.G., Stevens, E.J., Wolfort, S.F., et al. Common virulence factors for bacterial pathogenicity in plants and animals. Science 268 (1995), 1899–1902.
37. 37 Douzi, B., Ball, G., Cambillau, C., et al. Deciphering the Xcp Pseudomonas aeruginosa type II secretion machinery through multiple interactions with substrates. J Biol Chem 286 (2011), 40792–40801.
38. 38 Ley, R.E., Peterson, D.A., Gordon, J.I., Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124 (2006), 837–848.
39. 39 Dethlefsen, L., McFall-Ngai, M., Relman, D.A., An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449 (2007), 811–818.
40. 40 Stefka, A.T., Feehley, T., Tripathi, P., et al. Commensal bacteria protect against food allergen sensitization. Proc Natl Acad Sci U S A 111 (2014), 13145–13150.
41. 41 Sanz, Y., De Pama, G., Laparra, M., Unraveling the ties between celiac disease and intestinal microbiota. Int Rev Immunol 30 (2011), 207–218.
42. 42 Koning, F., Adverse effects of wheat gluten. Ann Nutr Metab 67:Suppl 2 (2015), 8–14.
43. 43 Lahdeaho, M.L., Kaukinen, K., Laurila, K., et al. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease. Gastroenterology 146 (2014), 1649–1658.
44. 44 Tack, G.J., van de Water, J.M., Bruins, M.J., et al. Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study. World J Gastroenterol 19 (2013), 5837–5847.
45. 45 Shan, L., Marti, T., Sollid, L.M., et al. Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue. Biochem J 383 (2004), 311–318.
46. 46 Wei, G., Tian, N., Valery, A.C., et al. Identification of pseudolysin (lasB) as an Aciduric gluten-degrading enzyme with high therapeutic potential for celiac disease. Am J Gastroenterol 110 (2015), 899–908.
47. 47 Milani, A., Vecchietti, D., Rusmini, R., et al. TgpA, a protein with a eukaryotic-like transglutaminase domain, plays a critical role in the viability of Pseudomonas aeruginosa. PLoS One, 7, 2012, e50323.
48. 48 Cathcart, G.R., Quinn, D., Greer, B., et al. Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection. Antimicrob Agents Chemother 55 (2011), 2670–2678.
49. 49 Sarno, M., Lania, G., Cuomo, M., et al. Lactobacillus paracasei CBA L74 interferes with gliadin peptides entrance in Caco-2 cells. Int J Food Sci Nutr 65 (2014), 953–959.
50. 50 D'Arienzo, R., Maurano, F., Luongo, D., et al. Adjuvant effect of Lactobacillus casei in a mouse model of gluten sensitivity. Immunol Lett 119 (2008), 78–83.
51. 51 Galipeau, H.J., Wiepjes, M., Motta, J.P., et al. Novel role of the serine protease inhibitor elafin in gluten-related disorders. Am J Gastroenterol 109 (2014), 748–756.